rs230703

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001355436.2(SPTB):​c.876+5A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.315 in 1,612,972 control chromosomes in the GnomAD database, including 84,087 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 11223 hom., cov: 33)
Exomes 𝑓: 0.31 ( 72864 hom. )

Consequence

SPTB
NM_001355436.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00007788
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.737

Publications

16 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 14-64800751-T-C is Benign according to our data. Variant chr14-64800751-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 257138.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.524 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.876+5A>G splice_region_variant, intron_variant Intron 8 of 35 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.876+5A>G splice_region_variant, intron_variant Intron 8 of 35 NM_001355436.2 ENSP00000495909.1 P11277-2
SPTBENST00000389722.7 linkc.876+5A>G splice_region_variant, intron_variant Intron 7 of 34 2 ENSP00000374372.3 P11277-2
SPTBENST00000389720.4 linkc.876+5A>G splice_region_variant, intron_variant Intron 8 of 31 5 ENSP00000374370.4 P11277-1

Frequencies

GnomAD3 genomes
AF:
0.366
AC:
55582
AN:
151960
Hom.:
11207
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.530
Gnomad AMI
AF:
0.398
Gnomad AMR
AF:
0.293
Gnomad ASJ
AF:
0.369
Gnomad EAS
AF:
0.153
Gnomad SAS
AF:
0.432
Gnomad FIN
AF:
0.307
Gnomad MID
AF:
0.339
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.363
GnomAD2 exomes
AF:
0.316
AC:
79366
AN:
251104
AF XY:
0.322
show subpopulations
Gnomad AFR exome
AF:
0.539
Gnomad AMR exome
AF:
0.232
Gnomad ASJ exome
AF:
0.371
Gnomad EAS exome
AF:
0.133
Gnomad FIN exome
AF:
0.301
Gnomad NFE exome
AF:
0.306
Gnomad OTH exome
AF:
0.327
GnomAD4 exome
AF:
0.309
AC:
452024
AN:
1460894
Hom.:
72864
Cov.:
33
AF XY:
0.313
AC XY:
227847
AN XY:
726808
show subpopulations
African (AFR)
AF:
0.541
AC:
18103
AN:
33468
American (AMR)
AF:
0.242
AC:
10828
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.378
AC:
9869
AN:
26132
East Asian (EAS)
AF:
0.162
AC:
6418
AN:
39690
South Asian (SAS)
AF:
0.425
AC:
36682
AN:
86232
European-Finnish (FIN)
AF:
0.302
AC:
16105
AN:
53408
Middle Eastern (MID)
AF:
0.383
AC:
2202
AN:
5752
European-Non Finnish (NFE)
AF:
0.299
AC:
332154
AN:
1111154
Other (OTH)
AF:
0.326
AC:
19663
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
15857
31714
47571
63428
79285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10968
21936
32904
43872
54840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.366
AC:
55624
AN:
152078
Hom.:
11223
Cov.:
33
AF XY:
0.364
AC XY:
27064
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.530
AC:
21984
AN:
41478
American (AMR)
AF:
0.293
AC:
4475
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.369
AC:
1278
AN:
3468
East Asian (EAS)
AF:
0.153
AC:
790
AN:
5164
South Asian (SAS)
AF:
0.431
AC:
2077
AN:
4814
European-Finnish (FIN)
AF:
0.307
AC:
3254
AN:
10584
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.302
AC:
20546
AN:
67966
Other (OTH)
AF:
0.358
AC:
757
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1737
3473
5210
6946
8683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
520
1040
1560
2080
2600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.330
Hom.:
28776
Bravo
AF:
0.368
Asia WGS
AF:
0.322
AC:
1121
AN:
3478
EpiCase
AF:
0.317
EpiControl
AF:
0.317

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 18, 2022
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spherocytosis type 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
6.8
DANN
Benign
0.54
PhyloP100
-0.74
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000078
dbscSNV1_RF
Benign
0.020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs230703; hg19: chr14-65267469; COSMIC: COSV67635994; API